Identification of Targetable HER2 Aberrations in Head and Neck Squamous Cell Carcinoma

IMPORTANCE: HER2 is an important drug target in breast cancer, where anti-HER2 therapy has been shown to lead to improvements in disease recurrence and overall survival. HER2 status in head and neck squamous cell carcinoma (HNSCC) has not been well studied. Identification of HER2 positive tumors and...

詳細記述

保存先:
書誌詳細
出版年:JAMA Otolaryngol Head Neck Surg
主要な著者: Birkeland, Andrew C., Yanik, Megan, Tillman, Brittny N., Scott, Megan V., Foltin, Susan K., Mann, Jacqueline E., Michmerhuizen, Nicole L., Ludwig, Megan L., Sandelski, Morgan M., Komarck, Christine M., Carey, Thomas E., Prince, Mark E.P., Bradford, Carol R., McHugh, Jonathan B., Spector, Matthew E., Brenner, J. Chad
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4911238/
https://ncbi.nlm.nih.gov/pubmed/27077364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoto.2016.0335
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料